Global Recombinant Dna Vaccines Market Report 2019, Competitive Landscape, Trends and Opportunities

1 Recombinant Dna Vaccines Market Overview

1.1 Product Overview and Scope of Recombinant Dna Vaccines

1.2 Recombinant Dna Vaccines Segment by Type

1.2.1 Global Recombinant Dna Vaccines Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Type 1

1.2.3 The Market Profile of Type 2

1.2.4 The Market Profile of Type 3

1.3 Global Recombinant Dna Vaccines Segment by Application

1.3.1 Recombinant Dna Vaccines Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Application 1

1.3.3 The Market Profile of Application 2

1.3.4 The Market Profile of Application 3

1.4 Global Recombinant Dna Vaccines Market by Region (2014-2026)

1.4.1 Global Recombinant Dna Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.3 Europe Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.3.1 Germany Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.3.2 UK Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.3.3 France Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.3.4 Italy Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.3.5 Spain Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.3.6 Russia Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.3.7 Poland Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.4 China Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.5 Japan Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.6 India Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.8 Central and South America Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Recombinant Dna Vaccines Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Recombinant Dna Vaccines (2014-2026)

1.5.1 Global Recombinant Dna Vaccines Revenue Status and Outlook (2014-2026)

1.5.2 Global Recombinant Dna Vaccines Production Status and Outlook (2014-2026)

2 Global Recombinant Dna Vaccines Market Landscape by Player

2.1 Global Recombinant Dna Vaccines Production and Share by Player (2014-2019)

2.2 Global Recombinant Dna Vaccines Revenue and Market Share by Player (2014-2019)

2.3 Global Recombinant Dna Vaccines Average Price by Player (2014-2019)

2.4 Recombinant Dna Vaccines Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Recombinant Dna Vaccines Market Competitive Situation and Trends

2.5.1 Recombinant Dna Vaccines Market Concentration Rate

2.5.2 Recombinant Dna Vaccines Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 MedImmune (US)

3.1.1 MedImmune (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.1.3 MedImmune (US) Recombinant Dna Vaccines Market Performance (2014-2019)

3.1.4 MedImmune (US) Business Overview

3.2 Bavarian Nordic A/S (Denmark)

3.2.1 Bavarian Nordic A/S (Denmark) Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.2.3 Bavarian Nordic A/S (Denmark) Recombinant Dna Vaccines Market Performance (2014-2019)

3.2.4 Bavarian Nordic A/S (Denmark) Business Overview

3.3 Zydus Cadila (India)

3.3.1 Zydus Cadila (India) Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.3.3 Zydus Cadila (India) Recombinant Dna Vaccines Market Performance (2014-2019)

3.3.4 Zydus Cadila (India) Business Overview

3.4 ALK - Abello A/S (Denmark)

3.4.1 ALK - Abello A/S (Denmark) Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.4.3 ALK - Abello A/S (Denmark) Recombinant Dna Vaccines Market Performance (2014-2019)

3.4.4 ALK - Abello A/S (Denmark) Business Overview

3.5 Takeda Pharmaceutical Company Limited (Japan)

3.5.1 Takeda Pharmaceutical Company Limited (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.5.3 Takeda Pharmaceutical Company Limited (Japan) Recombinant Dna Vaccines Market Performance (2014-2019)

3.5.4 Takeda Pharmaceutical Company Limited (Japan) Business Overview

3.6 Shanghai BravoBio Co., Ltd. (China)

3.6.1 Shanghai BravoBio Co., Ltd. (China) Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.6.3 Shanghai BravoBio Co., Ltd. (China) Recombinant Dna Vaccines Market Performance (2014-2019)

3.6.4 Shanghai BravoBio Co., Ltd. (China) Business Overview

3.7 Pfizer Inc. (US)

3.7.1 Pfizer Inc. (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.7.3 Pfizer Inc. (US) Recombinant Dna Vaccines Market Performance (2014-2019)

3.7.4 Pfizer Inc. (US) Business Overview

3.8 Altimmune, Inc. (US)

3.8.1 Altimmune, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.8.3 Altimmune, Inc. (US) Recombinant Dna Vaccines Market Performance (2014-2019)

3.8.4 Altimmune, Inc. (US) Business Overview

3.9 Serum Institute of India Pvt. Ltd. (India)

3.9.1 Serum Institute of India Pvt. Ltd. (India) Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.9.3 Serum Institute of India Pvt. Ltd. (India) Recombinant Dna Vaccines Market Performance (2014-2019)

3.9.4 Serum Institute of India Pvt. Ltd. (India) Business Overview

3.10 GlaxoSmithKline Plc. (UK)

3.10.1 GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.10.3 GlaxoSmithKline Plc. (UK) Recombinant Dna Vaccines Market Performance (2014-2019)

3.10.4 GlaxoSmithKline Plc. (UK) Business Overview

3.11 BiondVax Pharmaceuticals Ltd. (Israel)

3.11.1 BiondVax Pharmaceuticals Ltd. (Israel) Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.11.3 BiondVax Pharmaceuticals Ltd. (Israel) Recombinant Dna Vaccines Market Performance (2014-2019)

3.11.4 BiondVax Pharmaceuticals Ltd. (Israel) Business Overview

3.12 Merck & Co., Inc. (US)

3.12.1 Merck & Co., Inc. (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.12.3 Merck & Co., Inc. (US) Recombinant Dna Vaccines Market Performance (2014-2019)

3.12.4 Merck & Co., Inc. (US) Business Overview

3.13 SK Chemicals Co., Ltd. (Korea)

3.13.1 SK Chemicals Co., Ltd. (Korea) Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.13.3 SK Chemicals Co., Ltd. (Korea) Recombinant Dna Vaccines Market Performance (2014-2019)

3.13.4 SK Chemicals Co., Ltd. (Korea) Business Overview

3.14 Sanofi Pasteur SA (France)

3.14.1 Sanofi Pasteur SA (France) Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.14.3 Sanofi Pasteur SA (France) Recombinant Dna Vaccines Market Performance (2014-2019)

3.14.4 Sanofi Pasteur SA (France) Business Overview

3.15 Seqirus (UK)

3.15.1 Seqirus (UK) Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.15.3 Seqirus (UK) Recombinant Dna Vaccines Market Performance (2014-2019)

3.15.4 Seqirus (UK) Business Overview

3.16 Janssen Pharmaceuticals, Inc. (US)

3.16.1 Janssen Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.16.3 Janssen Pharmaceuticals, Inc. (US) Recombinant Dna Vaccines Market Performance (2014-2019)

3.16.4 Janssen Pharmaceuticals, Inc. (US) Business Overview

3.17 Hualan Biological Engineering Inc. (China)

3.17.1 Hualan Biological Engineering Inc. (China) Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.17.3 Hualan Biological Engineering Inc. (China) Recombinant Dna Vaccines Market Performance (2014-2019)

3.17.4 Hualan Biological Engineering Inc. (China) Business Overview

3.18 Bharat Biotech International Limited (India)

3.18.1 Bharat Biotech International Limited (India) Basic Information, Manufacturing Base, Sales Area and Competitors

3.18.2 Recombinant Dna Vaccines Product Profiles, Application and Specification

3.18.3 Bharat Biotech International Limited (India) Recombinant Dna Vaccines Market Performance (2014-2019)

3.18.4 Bharat Biotech International Limited (India) Business Overview

4 Global Recombinant Dna Vaccines Production, Revenue (Value), Price Trend by Type

4.1 Global Recombinant Dna Vaccines Production and Market Share by Type (2014-2019)

4.2 Global Recombinant Dna Vaccines Revenue and Market Share by Type (2014-2019)

4.3 Global Recombinant Dna Vaccines Price by Type (2014-2019)

4.4 Global Recombinant Dna Vaccines Production Growth Rate by Type (2014-2019)

4.4.1 Global Recombinant Dna Vaccines Production Growth Rate of Type 1 (2014-2019)

4.4.2 Global Recombinant Dna Vaccines Production Growth Rate of Type 2 (2014-2019)

4.4.3 Global Recombinant Dna Vaccines Production Growth Rate of Type 3 (2014-2019)

5 Global Recombinant Dna Vaccines Market Analysis by Application

5.1 Global Recombinant Dna Vaccines Consumption and Market Share by Application (2014-2019)

5.2 Global Recombinant Dna Vaccines Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Recombinant Dna Vaccines Consumption Growth Rate of Application 1 (2014-2019)

5.2.2 Global Recombinant Dna Vaccines Consumption Growth Rate of Application 2 (2014-2019)

5.2.3 Global Recombinant Dna Vaccines Consumption Growth Rate of Application 3 (2014-2019)

6 Global Recombinant Dna Vaccines Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Recombinant Dna Vaccines Consumption by Region (2014-2019)

6.2 United States Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

6.3 Europe Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

6.4 China Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

6.5 Japan Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

6.6 India Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

7 Global Recombinant Dna Vaccines Production, Revenue (Value) by Region (2014-2019)

7.1 Global Recombinant Dna Vaccines Production and Market Share by Region (2014-2019)

7.2 Global Recombinant Dna Vaccines Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

8 Recombinant Dna Vaccines Manufacturing Analysis

8.1 Recombinant Dna Vaccines Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Recombinant Dna Vaccines

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Recombinant Dna Vaccines Industrial Chain Analysis

9.2 Raw Materials Sources of Recombinant Dna Vaccines Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Recombinant Dna Vaccines

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Recombinant Dna Vaccines Market Forecast (2019-2026)

11.1 Global Recombinant Dna Vaccines Production, Revenue Forecast (2019-2026)

11.1.1 Global Recombinant Dna Vaccines Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Recombinant Dna Vaccines Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Recombinant Dna Vaccines Price and Trend Forecast (2019-2026)

11.2 Global Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Recombinant Dna Vaccines Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Recombinant Dna Vaccines Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Recombinant Dna Vaccines Product Picture

Table Global Recombinant Dna Vaccines Production and CAGR (%) Comparison by Type

Table Profile of Type 1

Table Profile of Type 2

Table Profile of Type 3

Table Recombinant Dna Vaccines Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Application 1

Table Profile of Application 2

Table Profile of Application 3

Figure Global Recombinant Dna Vaccines Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Europe Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Germany Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure UK Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure France Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Italy Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Spain Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Russia Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Poland Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure China Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Japan Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure India Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Malaysia Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Singapore Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Philippines Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Indonesia Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Thailand Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Vietnam Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Central and South America Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Brazil Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Mexico Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Colombia Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Turkey Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Egypt Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure South Africa Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Nigeria Recombinant Dna Vaccines Revenue and Growth Rate (2014-2026)

Figure Global Recombinant Dna Vaccines Production Status and Outlook (2014-2026)

Table Global Recombinant Dna Vaccines Production by Player (2014-2019)

Table Global Recombinant Dna Vaccines Production Share by Player (2014-2019)

Figure Global Recombinant Dna Vaccines Production Share by Player in 2018

Table Recombinant Dna Vaccines Revenue by Player (2014-2019)

Table Recombinant Dna Vaccines Revenue Market Share by Player (2014-2019)

Table Recombinant Dna Vaccines Price by Player (2014-2019)

Table Recombinant Dna Vaccines Manufacturing Base Distribution and Sales Area by Player

Table Recombinant Dna Vaccines Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table MedImmune (US) Profile

Table MedImmune (US) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Bavarian Nordic A/S (Denmark) Profile

Table Bavarian Nordic A/S (Denmark) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Zydus Cadila (India) Profile

Table Zydus Cadila (India) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table ALK - Abello A/S (Denmark) Profile

Table ALK - Abello A/S (Denmark) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Takeda Pharmaceutical Company Limited (Japan) Profile

Table Takeda Pharmaceutical Company Limited (Japan) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Shanghai BravoBio Co., Ltd. (China) Profile

Table Shanghai BravoBio Co., Ltd. (China) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Inc. (US) Profile

Table Pfizer Inc. (US) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Altimmune, Inc. (US) Profile

Table Altimmune, Inc. (US) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Serum Institute of India Pvt. Ltd. (India) Profile

Table Serum Institute of India Pvt. Ltd. (India) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table GlaxoSmithKline Plc. (UK) Profile

Table GlaxoSmithKline Plc. (UK) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table BiondVax Pharmaceuticals Ltd. (Israel) Profile

Table BiondVax Pharmaceuticals Ltd. (Israel) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Merck & Co., Inc. (US) Profile

Table Merck & Co., Inc. (US) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table SK Chemicals Co., Ltd. (Korea) Profile

Table SK Chemicals Co., Ltd. (Korea) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Sanofi Pasteur SA (France) Profile

Table Sanofi Pasteur SA (France) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Seqirus (UK) Profile

Table Seqirus (UK) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Janssen Pharmaceuticals, Inc. (US) Profile

Table Janssen Pharmaceuticals, Inc. (US) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Hualan Biological Engineering Inc. (China) Profile

Table Hualan Biological Engineering Inc. (China) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Bharat Biotech International Limited (India) Profile

Table Bharat Biotech International Limited (India) Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Recombinant Dna Vaccines Production by Type (2014-2019)

Table Global Recombinant Dna Vaccines Production Market Share by Type (2014-2019)

Figure Global Recombinant Dna Vaccines Production Market Share by Type in 2018

Table Global Recombinant Dna Vaccines Revenue by Type (2014-2019)

Table Global Recombinant Dna Vaccines Revenue Market Share by Type (2014-2019)

Figure Global Recombinant Dna Vaccines Revenue Market Share by Type in 2018

Table Recombinant Dna Vaccines Price by Type (2014-2019)

Figure Global Recombinant Dna Vaccines Production Growth Rate of Type 1 (2014-2019)

Figure Global Recombinant Dna Vaccines Production Growth Rate of Type 2 (2014-2019)

Figure Global Recombinant Dna Vaccines Production Growth Rate of Type 3 (2014-2019)

Table Global Recombinant Dna Vaccines Consumption by Application (2014-2019)

Table Global Recombinant Dna Vaccines Consumption Market Share by Application (2014-2019)

Table Global Recombinant Dna Vaccines Consumption of Application 1 (2014-2019)

Table Global Recombinant Dna Vaccines Consumption of Application 2 (2014-2019)

Table Global Recombinant Dna Vaccines Consumption of Application 3 (2014-2019)

Table Global Recombinant Dna Vaccines Consumption by Region (2014-2019)

Table Global Recombinant Dna Vaccines Consumption Market Share by Region (2014-2019)

Table United States Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

Table Europe Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

Table China Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

Table Japan Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

Table India Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

Table Central and South America Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Recombinant Dna Vaccines Production, Consumption, Export, Import (2014-2019)

Table Global Recombinant Dna Vaccines Production by Region (2014-2019)

Table Global Recombinant Dna Vaccines Production Market Share by Region (2014-2019)

Figure Global Recombinant Dna Vaccines Production Market Share by Region (2014-2019)

Figure Global Recombinant Dna Vaccines Production Market Share by Region in 2018

Table Global Recombinant Dna Vaccines Revenue by Region (2014-2019)

Table Global Recombinant Dna Vaccines Revenue Market Share by Region (2014-2019)

Figure Global Recombinant Dna Vaccines Revenue Market Share by Region (2014-2019)

Figure Global Recombinant Dna Vaccines Revenue Market Share by Region in 2018

Table Global Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table China Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table India Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Recombinant Dna Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Recombinant Dna Vaccines

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Recombinant Dna Vaccines

Figure Recombinant Dna Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Recombinant Dna Vaccines Major Players in 2018

Table Downstream Buyers

Figure Global Recombinant Dna Vaccines Production and Growth Rate Forecast (2019-2026)

Figure Global Recombinant Dna Vaccines Revenue and Growth Rate Forecast (2019-2026)

Figure Global Recombinant Dna Vaccines Price and Trend Forecast (2019-2026)

Table United States Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

Table China Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

Table India Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Recombinant Dna Vaccines Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Recombinant Dna Vaccines Market Production Forecast, by Type

Table Global Recombinant Dna Vaccines Production Volume Market Share Forecast, by Type

Table Global Recombinant Dna Vaccines Market Revenue Forecast, by Type

Table Global Recombinant Dna Vaccines Revenue Market Share Forecast, by Type

Table Global Recombinant Dna Vaccines Price Forecast, by Type

Table Global Recombinant Dna Vaccines Market Production Forecast, by Application

Table Global Recombinant Dna Vaccines Production Volume Market Share Forecast, by Application

Table Global Recombinant Dna Vaccines Market Revenue Forecast, by Application

Table Global Recombinant Dna Vaccines Revenue Market Share Forecast, by Application

Table Global Recombinant Dna Vaccines Price Forecast, by Application